semaglutide and trevogrumab Explained: The Muscle-Sparing GLP-1 Add-On Regeneron Phase 2b Study Shows

Retatrutide, by adding glucagon receptor activation, has raised the bar to over 2224%

Notable effects associated with the approval of semaglutide for weight loss include a significant reduction in body weight and improvements in cardiovascular risk factors

By Increasing Insulin Release and Reducing Glucagon, Ozempic Helps Lower Blood Sugar Levels and Can Support Weight Loss

After surgery, plasma GLP-1 and PYY concentrations increased significantly at 30 min postprandially in response to both inulin and MDX when compared to baseline ( P 0.05, respectively, Fig

Who qualifies for a GLP-1 prescription in Ireland

Nature Health, 10 April 2026